Can a clubhouse model sharpen thinking in schizophrenia? new study aims to find out
NCT ID NCT07006935
First seen Jun 26, 2026 · Last updated Aug 18, 2026 · Updated 3 times
Summary
This pilot study will compare the Clubhouse Model—a structured, community-based program where members work together to run the clubhouse—to standard outpatient care for adults with schizophrenia. Researchers will measure changes in thinking, daily functioning, and brain activity using cognitive tests and MRI scans over six months. The goal is to understand if this social approach has unique benefits for the brain and real-world skills.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Clubhouse Model of Psychosocial Rehabilitation
- What this could lead to
- If successful, this study could show that the Clubhouse Model improves cognitive function and quality of life for people with schizophrenia, pointing toward a non-drug approach to support recovery.
- What could go wrong
- This is a very small pilot study (30 people) that is not yet recruiting. It only measures changes over 6 months, so results may not apply broadly or prove long-term benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Jan 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * (1) have a DSM-V diagnosis of schizophrenia, schizoaffective disorder, or schizophreniform confirmed by diagnostic assessment and medical record review * (2) between the ages of 18-50 * (3) stabilized on psychotropic medication as indicated by no changes to the primary psychiatric medication in the last month * (4) able to read and speak fluent English at a sixth grade level or higher for purposes of informed consent and cognitive testing * For Clubhouse members, they must be a first-time, newly enrolled member Exclusion Criteria: * (1) had previous membership at a Clubhouse (Magnolia or elsewhere) * (2) have a current severe substance use disorder * (3) have persistent suicidal or homicidal behavior * (4) a co-occurring diagnosis of an intellectual or learning disability or neurodevelopment condition (e.g., Autism; based on chart review) * (5) had recent psychiatric instability requiring hospitalization in the past month; * (6) history of a traumatic brain injury (TBI; based on record review) * (7) contraindicators for MRI (e.g., pacemaker, claustrophobia) * Participants in the usual care will be excluded if they are a current Clubhouse member or join a Clubhouse during participation in this research
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Schizo affective disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Case Western Reserve University
RECRUITINGCleveland, Ohio, 44106, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists probe brain's reward system in mental illness
- New schizophrenia drug targets brain glutamate, not dopamine
- New drug candidate takes aim at schizophrenia symptoms
- New schizophrenia drug goes Head-to-Head with standard antipsychotics in Long-Term trial
- Five-Year safety check for experimental schizophrenia drug
- A shot every few weeks? new drug tested for schizophrenia